Back to search

Ireland· IE-PA-PA23180/017/001

Dulcolax Pico Liquid 5 mg/5 ml oral solution

A sodium picosulfate product containing sodium picosulfate, registered in Ireland by Opella Healthcare France SAS T/A Sanofi. The same ATC class is registered in 12 of our 19 countries.

ATC A06AB08

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedDulcolax Pico Liquid 5 mg/5 ml oral s…ATCA06AB08REGISTER NO.IE-PA-PA23180/017/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Sodium picosulfate is registered in 12 of 19 countries.

Countries holding a registration under ATC A06AB08 (sodium picosulfate), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Sodium picosulfate · ATC A06AB08

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Sodium picosulfate
Manufacturer
Opella Healthcare France SAS T/A Sanofi
Country
Ireland (IE)
ATC code
A06AB08
ATC class
Sodium picosulfate
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23180/017/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

516 interactions on record for sodium picosulfate.

Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sodium picosulfate · interactions on record

516 records

  • 37 severe
  • 475 moderate
  • 4 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • ProcainamideC01BA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sodium picosulfate in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium picosulfate products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Agaffin, Guttalax
  • Belgium · Dulcolax Picosulphate, Fructines
  • Bulgaria · Глицеракс Пико, Дулколакс Пико
  • Czechia · Gallax, Guttalax
  • Germany · Dulcolax Np Perlen, Dulcolax Np Tropfen
  • Denmark · Actilax, Laxoberal
  • Estonia · Guttalax, Regulax
  • Spain · Dulcolax Picosulfato, Evacuol
  • Finland · Laxoberon, Picorion
  • France · Fructines
  • United Kingdom (Northern Ireland) · Dulcolax Adult Pico Liquid, Dulcolax Adult Pico Perles
  • Greece · Dulcoflex
  • Hungary · Dulcolax, Stadalax
  • Iceland · Laxoberal
  • Italy · Euchessina C.M., Gocce Lassative Aicardi
  • Lithuania · Regulax
  • Luxembourg · Laxoberon
  • Latvia · Guttalax, Regulax
  • Malta · Dulcolax Pico Liquid
  • Norway · Laxoberal
  • Poland · Pikopil
  • Portugal · Dulcolax Gotas, Enterex
  • Romania · Dulcopic
  • Sweden · Cilaxoral, Laxoberal
  • Slovakia · Guttalax, Laxygal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/47a69ec0-c5da-4336-99a7-4d3df92793b9
GET /v1/drugs/47a69ec0-c5da-4336-99a7-4d3df92793b9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral solution",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A06AB",
    "A06AB08"
  ],
  "strength": null,
  "pa_number": "PA23180/017/001",
  "substances": [
    "Sodium picosulfate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "31/08/1975",
  "dispensing_status": "Product not subject to medical prescription",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about sodium picosulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.